GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » Inventory-to-Revenue

China Isotope & Radiation (HKSE:01763) Inventory-to-Revenue : 0.34 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. China Isotope & Radiation's Average Total Inventories for the quarter that ended in Jun. 2024 was HK$1,032 Mil. China Isotope & Radiation's Revenue for the six months ended in Jun. 2024 was HK$3,025 Mil. China Isotope & Radiation's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.34.

China Isotope & Radiation's Inventory-to-Revenue for the quarter that ended in Jun. 2024 increased from Dec. 2023 (0.21) to Dec. 2023 (0.34)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. China Isotope & Radiation's Days Inventory for the six months ended in Jun. 2024 was 129.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. China Isotope & Radiation's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.40.


China Isotope & Radiation Inventory-to-Revenue Historical Data

The historical data trend for China Isotope & Radiation's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation Inventory-to-Revenue Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.10 0.12 0.12 0.12 0.11

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.22 0.28 0.21 0.34

Competitive Comparison of China Isotope & Radiation's Inventory-to-Revenue

For the Medical Devices subindustry, China Isotope & Radiation's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's Inventory-to-Revenue falls into.



China Isotope & Radiation Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

China Isotope & Radiation's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (757.758 + 890.516) / 2 ) / 7257.214
=824.137 / 7257.214
=0.11

China Isotope & Radiation's Inventory-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue (Q: Jun. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Jun. 2024 )) / count ) / Revenue (Q: Jun. 2024 )
=( (890.516 + 1172.991) / 2 ) / 3025.388
=1031.7535 / 3025.388
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation  (HKSE:01763) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

China Isotope & Radiation's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=1031.7535/1449.167*365 / 2
=129.93

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

China Isotope & Radiation's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2024 ) / Average Total Inventories (Q: Jun. 2024 )
=1449.167 / 1031.7535
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Li Hongbo 2201 Interest of corporation controlled by you
Lianwen Ltd 2101 Beneficial owner
Invesco Advisers, Inc. 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Invesco Hong Kong Limited 2102 Investment manager
Invesco Corporate Class Inc. 2106 Person having a security interest in shares
M&g Plc 2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited 2101 Beneficial owner
Serenity Capital Management, Ltd. 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd. 2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited 2201 Interest of corporation controlled by you

China Isotope & Radiation Headlines

No Headlines